KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles: 2009-2024

Historic Amortizatization of Intangibles for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $15.0 million.

  • Acadia Pharmaceuticals' Amortizatization of Intangibles rose 16.17% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 11.92%. This contributed to the annual value of $15.0 million for FY2024, which is 98.63% up from last year.
  • As of FY2024, Acadia Pharmaceuticals' Amortizatization of Intangibles stood at $15.0 million, which was up 98.63% from $7.5 million recorded in FY2023.
  • In the past 5 years, Acadia Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $15.0 million in FY2024 and a low of -$2.4 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $8.4 million, with a median of $7.5 million in 2023.
  • In the last 5 years, Acadia Pharmaceuticals' Amortizatization of Intangibles slumped by 260.27% in 2021 and then skyrocketed by 213.81% in 2022.
  • Acadia Pharmaceuticals' Amortizatization of Intangibles (Yearly) stood at $1.5 million in 2020, then tumbled by 260.27% to -$2.4 million in 2021, then skyrocketed by 213.81% to $2.7 million in 2022, then surged by 175.33% to $7.5 million in 2023, then spiked by 98.63% to $15.0 million in 2024.